Elissar Moujaess

7PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 10, 2026
The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma.

Elissar Moujaes, Jules Dupont, Littisha Lawrance

|May 24, 2022
Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?

Mariana Boulos, Elissar Moujaes, Ghazi Nsouli

|Aug 31, 2021
Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need?

Elissar Moujaess, Reine Merhy, Joseph Kattan

|Aug 19, 2021
Molecular pathogenesis of hereditary lung cancer: a literature review.

Souraya Rammal, Hampig Raphael Kourie, Nadine Jalkh

|Aug 02, 2021
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey.

Elissar Moujaess, Naji Bou Zeid, Ramy Samaha

|Jun 21, 2021
First advanced course on biomarkers in molecular and immuno-oncology in the Middle East.

Elissar Moujaess, Makram Khoury, Joseph Zouein

Pageof 2

Frequent Collaborators

2 joint publications

Hampig Raphael Kourie

1 joint publications

Jules Dupont

1 joint publications

Littisha Lawrance

1 joint publications

Caroline Su